Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.756191
Title: Metabolic consequences of cellular exposure to decanoic acid
Author: Khabbush, Aziza
ISNI:       0000 0004 7429 1445
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2018
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
The medium-chain triglyceride ketogenic diet (MCT KD) is an effective treatment for drug-resistant epilepsy. However, its complexity and associated side effects necessitate the need for improved therapeutic strategies. Although the exact mechanisms for its efficacy remain unknown, there is a growing interest in the potential roles of mediumchain fatty acids octanoic (C8) and decanoic (C10) acids, present in MCT oil administered in the diet and found to be elevated in patient plasma. Moreover, it is emerging that C10, but not C8, elicits anti-seizure effects, inhibits AMPA receptor, and enhances neuronal catalase activity and mitochondrial biogenesis via peroxisome proliferator-activated receptor-γ (PPARγ). In this thesis, the biochemical and mitochondrial effects of C8 and C10 were further characterised in neuronal cell line SH-SY5Y, in addition to the effects of a C10-enriched MCT product in drug-resistant epilepsy patients. In cells treated for 6 days with 250μM of either fatty acid, C10, but not C8, was found to regulate mitochondrial content, as measured by mitochondrial enzyme marker citrate synthase (CS). The effect of C10 was observed to be dependent on control CS activity, increasing mitochondrial content in cells with low control levels and decreasing it in cells with high control activities. Furthermore, C10, but not C8, was found to raise mitochondrial membrane potential in cells, whilst neither of the two fatty acids were seen to affect cellular energy charge. The evidence suggests C10 may potentially optimise mitochondrial enrichment, generating mitochondria with increased function. For these effects to occur in the brain, however, significant concentrations are likely to be required. The neuronal β-oxidation rates of C8 and C10 were investigated and C10 β-oxidation was found to be significantly lower than that of C8. C10 β-oxidation was also found carnitine-dependent, whilst C8 was only partially dependent. In the presence of C8, C10 β-oxidation was further decreased. Consequently, C10 may be relatively spared from β-oxidation, permitting accumulation for it to exert its effects. In view of the evidence presented, the effects of a C10-enriched MCT product was examined in a feasibility study with drug-resistant epilepsy patients. Plasma levels of C8 and C10 were raised in participants. However, a lack of ketosis and no effects on blood lipid and acylcarnitine profiles were observed. Participants were found to have high baseline white blood cell CS activities, which decreased with treatment with the product. How these effects relate to seizure control remains to be determined, but the findings presented in this thesis suggest that a shift towards greater C10 enrichment in the MCT KD may be potentially beneficial.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.756191  DOI: Not available
Share: